newsfilter
← Latest News
GlobeNewswire·

Zealand Pharma to participate in the Jefferies Global Healthcare Conference

  • Zealand Pharma A/S (Nasdaq: ZEAL) announced CEO Adam Steensberg will attend the Jefferies Global Healthcare Conference in London.
  • The fireside chat is scheduled for Monday, November 16, 2026, at 12:30pm CET (06:30am ET).
  • A live audio webcast will be available at https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/4z8azbzzY9moovdWsmARdB.
  • The webcast will be archived on Zealand Pharma's investor website at https://www.zealandpharma.com/investors/events-presentations/.
  • Zealand Pharma has developed over 10 drug candidates, with 2 products on the market & 3 in late-stage development.
  • The company utilizes advanced data-driven & AI/ML approaches to advance medicines for obesity & metabolic health.
  • Zealand Pharma was founded in 1998 & is headquartered in Copenhagen, Denmark, with a U.S. office in Boston.
  • Investor & media contact details for Eric Rojas, Neshat Anis Ahmadi, Rachel James-Owens, & Andreas Hylleberg Mølleskov are provided.
Company
Zealand Pharma
Keywords
Copenhagen Stock Exchange:ZEAL, Zealand Pharma, healthcare conference